ライフサイエンスコーパス: osseous defect

1 tromal-cell-mediated bone regeneration in an osseous defect.

2 ated to the presence of residual char in the osseous defect.

3 ated to the presence of residual char in the osseous defect.

4 ade of the alveolar crest height and base of osseous defect.

5 anges in bone within the healed peri-implant osseous defect.

6 atients possessing one localized periodontal osseous defect.

7 anges in bone within the healed peri-implant osseous defect.

8 ne matrix (DBM) is used for the treatment of osseous defects.

9 of periodontal surgery and reconstitution of osseous defects.

10 nd effective in the treatment of periodontal osseous defects.

11 dontal membrane in the treatment of vertical osseous defects.

12 ABM/P-15 in long-term healing of periodontal osseous defects.

13 n suggested for the treatment of periodontal osseous defects.

14 bone replacement graft in human periodontal osseous defects.

15 rane in guided tissue regeneration (GTR) for osseous defects.

16 ts (90.9%) achieved complete coverage of the osseous defects.

17 s placed in sites with extended peri-implant osseous defects.

18 e its potential for treatment of periodontal osseous defects.

19 dement in the treatment of human periodontal osseous defects.

20 DFDBA) in the treatment of human periodontal osseous defects.

21 to the creation of bilateral mandibular 5 mm osseous defects.

22 n patients with localized severe periodontal osseous defects.

23 he vertical and horizontal dimensions of the osseous defects.

24 ene (ePTFE) membrane were utilized to repair osseous defects.

25 trabeculae and more trabecular separation in osseous defects.

26 were 1.5 mm greater, and the average fill of osseous defect 2.4 mm greater with EMD than controls.

27 Full thickness osseous defects (5 mm) were prepared in the cranium of i

28 was to determine which treatment of a large osseous defect adjacent to an endosseous dental implant

29 group C, submerged implants were placed into osseous defects and covered with an ePTFE membrane.

30 up A, nonsubmerged implants were placed into osseous defects and treated with a poncho style ePTFE me

31 med to determine changes in PD, CAL, fill of osseous defect, and crestal resorption.

32 mine changes in GI, PI, PD, CAL, fill of the osseous defect, and crestal resorption.

33 etermining three-dimensional architecture of osseous defects are inadequate.

34 thetic bioabsorbable carrier for BMP used in osseous defects around dental implants in the canine man

35 ix for the treatment of advanced periodontal osseous defects at 6 months of healing.

36 hickness mucoperiosteal flaps were elevated, osseous defects debrided, and the roots prepared (ultras

37 nd 1.18 mm on lingual sites at center B) and osseous defect fill (1.84 mm on buccal and 2.00 mm on li

38 .08 mm of new vertical bone height and 42.3% osseous defect fill in the HD-PDGF/IGF-I subjects versus

39 CONCLUSIONS: Diabetes significantly delayed osseous defect healing by augmenting inflammation, impai

40 tite scaffolds did not significantly enhance osseous defect healing compared with controls.

41 Twenty-four vertical osseous defects in 24 patients were treated with either

42 s compared to ABM alone in human periodontal osseous defects in a controlled, monitored, multi-center

43 flap debridement (DEBR) in human periodontal osseous defects in a controlled, monitored, multi-center

44 Paired osseous defects in each subject were randomly selected t

45 factor-I (IGF-I) when applied to periodontal osseous defects in humans; a secondary objective was to

46 are limited data on the healing potential of osseous defects in the human mandible.

47 Osseous defect measurements were taken at baseline and a

48 ve applications such as fracture healing and osseous defects of the oral cavity.

49 ; and 4) occlusal surface to the base of the osseous defect (OS-BD).

50 Two osseous defects per patient were treated randomly with e

51 Three osseous defects per patient were treated randomly with o

52 arriers proved suitable for achieving GBR of osseous defects surrounding dental implants.

53 regeneration (GBR) is a viable treatment for osseous defects surrounding dental implants.

54 eriodontal or peri-implant diseases to large osseous defects that extend through the jaws as a result

55 end on numerous factors and range from gross osseous defects to equivocal labral abnormalities and un

56 -entry data demonstrate that percent fill of osseous defects treated with EMD compares favorably with

57 olars were extracted, and a tooth-associated osseous defect was created in the extraction area.

58 cally conditioned with tetracycline, and the osseous defect was grafted with decalcified freeze-dried

59 Radiographic linear resolution of osseous defects was significantly greater after teripara

60 Artificial osseous defects were created on mandibles of dry skulls.

61 The osseous defects were then filled with demineralized free

62 ed at the apical extent of the calculus, the osseous defects were thoroughly debrided, and the tooth

63 Treatment of vertical osseous defects with nonporous or porous polytetrafluoro

64 ants placed directly into surgically created osseous defects with or without expanded polytetrafluoro

65 Patients had 3 osseous defects with probing depths (PD) > 5 mm after in

66 up B, nonsubmerged implants were placed into osseous defects without an ePTFE membrane.